Stock Market

Market Wrap: Stocks Fall as Industrials and Utilities Decline


Securities in This Article

Stock Market Update for the Trading Week Ended Aug. 21

  • The Morningstar US Total Market Index fell 1.48%.
  • The best-performing sectors were healthcare, up 4.19%, and energy, up 2.39%.
  • The worst-performing sectors were industrials, down 4.23%, and utilities, down 3.65%.
  • Large-cap stocks fell 1.48%, mid-cap stocks fell 1.82%, and small-cap stocks fell 1.46%.
  • Growth stocks fell 2.03%, blend stocks fell 1.48%, and value stocks fell 0.76%.
  • The S&P 500 fell 1.43%, and the Nasdaq fell 2.05%.
  • Of the 882 US-listed companies covered by Morningstar, 380, or 43%, were up, none were unchanged, and 501, or 57%, were down.

Bonds and Commodities

  • Yields on 10-year US Treasury notes rose to 4.74% from 4.68%.
  • Yields on 2-year US Treasury notes rose to 4.24% from 4.17%.
  • West Texas Intermediate crude prices rose 5.15% to $86.64 per barrel.
  • Comex Gold prices rose 5.38% to $4,609.20.

Top Stock Gainers

Moderna MRNA, Coinbase Global COIN, BioNTech BNTX, Argenx ARGX, and Hims & Hers Health HIMS were the top performers among US-listed stocks covered by Morningstar analysts.

  • Moderna topped the list, rising 129.17%, and it’s up 177.06% over the past three months. This no-moat company with a 3-star rating has increased 395.8% over the past 12 months. The stock closed the week at $145.13, trading at an 18% discount to its fair value estimate of $163.00 per share.
  • Coinbase was the second-best performer, with a weekly return of 25.62%. The 3-star stock has lost 9.9% over the last three months. Shares in this no-moat company are down 43.38% over the past 12 months. Coinbase stock wrapped up the week at $186.49, trading at a 15% premium to its fair value estimate of $150.00 per share.
  • BioNTech ranked third for the week, rising 25.26%. The 2-star, no-moat stock has gained 22.72% over the last three months but fell 0.37% over the past 12 months. BioNTech stock closed at $116.57, trading at a 46% premium to its fair value estimate of $76.00 per share.
  • The fourth-best-performing stock was no-moat Argenx, which gained 22.1%. The 3-star stock has gained 29.08% over the last three months and is up 57.06% over the past 12 months. Argenx finished the week at $1,039.78, trading at a 15% premium to its fair value estimate of $900.00 per share.
  • Hims & Hers Health climbed 20% this week. This no-moat company has increased 38.28% over the last three months but has declined 26.56% over the past 12 months. The 2-star stock ended the week at $33.78 per share, trading at a 39% premium to its fair value estimate of $23.00.

Top Stock Losers

Klarna Group KLAR, iQIYI IQ, Nebius Group NBIS, Cogent Communications Holdings CCOI, and CoreWeave CRWV did the worst among US-listed stocks covered by Morningstar analysts.

  • Klarna was the worst-performing stock of the week, falling 31.07%. This 5-star, narrow-moat company has fallen 12.99% over the past three months. The stock ended the week at $14.33, trading at a 63% discount to its fair value estimate of $38.30 per share.
  • iQIYI took the second spot, with a 22.14% price decline this week. The no-moat company, rated 1 star, has fallen 6.36% over the past three months and is down 55.22% over the past 12 months. Closing at $1.05, the stock trades at a 106% premium to its fair value estimate of $0.50 per share.
  • Nebius came in third, experiencing a 21.13% drop this week. This 2-star, no-moat company has risen 14.75% over the past three months and rose 226.23% over the past 12 months. The stock finished the week at $219.13, trading at a 47% premium to its fair value estimate of $150.00 per share.
  • Next up is Cogent, which fell 19.03% this week. The narrow-moat company with a 4-star rating has fallen 43.67% over the past three months and 70.44% over the past 12 months. At $9.17, the stock trades at a 41% discount to its fair value estimate of $17.00 per share.
  • CoreWeave rounds out the list with a 16.58% decline this week. This 3-star, no-moat company has fallen 11.37% over the past three months and fell 1.92% over the past 12 months. The stock closed the week at $87.85, trading at a 22% discount to its fair value estimate of $115.00 per share.

Highlights of This Week’s Market and Investing Events

The author or authors do not own shares in any securities mentioned in this article.

Find out about Morningstar’s editorial policies.



Source link

Leave a Response